e-learning
resources
Paris 2018
Sunday, 16.09.2018
Risk stratification in treatment of pulmonary arterial hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
emPHasis-10 score predicts mortality in patients with pulmonary hypertension
S. Wort (London, United Kingdom), C. Favoccia (London, United Kingdom), A. Kempny (London, United Kingdom), L. Price (London, United Kingdom), C. Mccabe (London, United Kingdom), K. Dimopoulos (London, United Kingdom)
Source:
International Congress 2018 – Risk stratification in treatment of pulmonary arterial hypertension
Session:
Risk stratification in treatment of pulmonary arterial hypertension
Session type:
Oral Presentation
Number:
273
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Wort (London, United Kingdom), C. Favoccia (London, United Kingdom), A. Kempny (London, United Kingdom), L. Price (London, United Kingdom), C. Mccabe (London, United Kingdom), K. Dimopoulos (London, United Kingdom). emPHasis-10 score predicts mortality in patients with pulmonary hypertension. 273
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
MPAP/CO-slope during exercise as predictor of mortality in patients at risk for pulmonary hypertension.
Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension
Year: 2020
A stepwise composite echocardiographic score predicts severe pulmonary hypertension in patients with interstitial lung disease
Source: ERJ Open Res, 4 (2) 00124-2017; 10.1183/23120541.00124-2017
Year: 2018
Pulmonary vascular resistance predicts mortality in patients with pulmonary hypertension associated with interstitial lung disease: results from the COMPERA registry
Source: Eur Respir J, 58 (2) 2101483; 10.1183/13993003.01483-2021
Year: 2021
Utility of D-Dimer for mortality prediction in patients at risk for pulmonary hypertension
Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Year: 2020
Risk assessment, therapy and cardiovascular comorbidity in patients with pulmonary arterial hypertension
Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Year: 2020
Elevated pulmonary vascular resistance predicts mortality in COPD patients
Source: Eur Respir J, 58 (2) 2100944; 10.1183/13993003.00944-2021
Year: 2021
The cardiovascular comorbidity and the risk of stroke by means of CHADS2- VASc scale in patients with chronic obstructive pulmonary disease.
Source: International Congress 2017 – Extrapulmonary comorbidities in COPD
Year: 2017
Hospitalization in patients with pulmonary arterial hypertension: causes and outcomes
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009
The association of diuretics treatment with hospitalization rates of patients with chronic obstructive pulmonary disease and pulmonary hypertension: a population-based study
Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Year: 2020
Analysis of mortality risk factors in a population with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary hypertension
Year: 2010
CT predictors of pulmonary hypertension in patients with severe COPD
Source: International Congress 2018 – Evaluation of COPD and various diseases by different imaging modalities
Year: 2018
Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension
Source: Eur Respir J 2010; 36: 549-555
Year: 2010
A clinical scoring algorithm to predict all cause mortality in COPD
Source: Annual Congress 2007 - Clinical aspects in COPD
Year: 2007
Impact of age and comorbidity on risk stratification in idiopathic pulmonary arterial hypertension
Source: Eur Respir J, 51 (5) 1702310; 10.1183/13993003.02310-2017
Year: 2018
Pulmonary vascular disease(PC) and risk of mortality in patients with idiopathic pulmonary fibrosis(IPF)
Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies
Year: 2018
Respiratory comorbidities and risk of mortality in hospitalized patients with idiopathic pulmonary fibrosis.
Source: International Congress 2017 – ILDs: clinical aspects
Year: 2017
Exercise ventilatory inefficiency is an independent predictor of mortality in patients with pulmonary arterial hypertension
Source: Annual Congress 2012 - Limiting factors in exercise
Year: 2012
The impact of immediate postoperative pulmonary vascular resistance on survival in patients with chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2009 - Pulmonary embolism
Year: 2009
External validation of the OPALS prediction model for in-hospital mortality in patients with acute decompensated pulmonary hypertension
Source: ERJ Open Res, 8 (1) 00006-2022; 10.1183/23120541.00006-2022
Year: 2022
Relationship between comorbidities and quality of life perceived by patients diagnosed with pulmonary hypertension: Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH)
Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept